Waldemar Debinski, MD, PhD
Professor of Surgery - Neurosurgery
Debinski, the director of the Brain Tumor Center of Excellence at Wake Forest Baptist, is a physician-scientist who pioneered a method to destroy malignant brain tumor cells without harming healthy cells. A drug developed by Debinski was an "unanticipated success" in early clinical trials and is now going through final testing in a phase-3 study. He is also researching brain tumor vaccines and new imaging techniques. He holds eight patents and has published more than 200 scientific reports. He won the Society of Neuro-Oncology's annual award for Excellence in Basic Research.
KeywordsTargeted therapies for brain cancer, brain cancer vaccine research, imaging, malignant brain tumors, Brain Tumor Center of Excellence, brain tumor vaccine